Skip to main content
Log in

Decrease of Intragastric Acidity in Healthy Subjects Dosed with Ranitidine 75 mg, Cimetidine 200 mg, or Placebo

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

This study assessed the duration of action of single doses of ranitidine (75 mg), cimetidine (200 mg), or placebo on intragastric acidity in healthy subjects. When dosed with placebo, mean daytime intragastric acidity (0–10 hr after dose) was 37.62 mmol/liter, decreasing to 17.21 mmol/liter (mean decrease 59%; P < 0.001 vs placebo) and 25.06 mmol/liter (mean decrease 35%; P < 0.001 vs placebo) when treated with ranitidine and cimetidine, respectively. Ranitidine inhibited intragastric acidity to a greater degree than cimetidine (P < 0.001). Mean nighttime (10–20 hr after-dose) intragastric acidity when dosed with placebo was 34.37 mmol/liter, decreasing to 29.06 mmol/liter (mean decrease 18%; P = 0.027 vs placebo) when dosed with ranitidine and remaining virtually unchanged at 33.85 mmol/liter (mean decrease 2%; NS vs. placebo) when dosed with cimetidine. Ranitidine inhibited acidity to a greater degree than cimetidine (P = 0.043). The inhibitory effect of ranitidine, 75 mg, on intragastric acidity can be detected from 0–15 hr after an oral dose. Cimetidine 200 mg has little inhibitory effect beyond 10 hr.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Committee on the Safety of Medicines. Medicines newly released for self-medication:Curr Probl Pharmacovigil 20:4, 1994

    Google Scholar 

  2. Mason P: Has reclassification of GI drugs changes the treatment of disease? Pharm J 257:731–732, 1996

    Google Scholar 

  3. Reilly TG, Mann SG, Panos MZ, Walt RP: Low-dose famotidine and cimetidine in single post-prandial doses: A placebo controlled comparative study of overnight pH. Gut 37:325–328, 1995

    Google Scholar 

  4. Reilly TG, Singh S, Cotterel J, Mann SG, Stauffer L, Walt RP: Low-dose famotidine and ranitidine as single post-prandial doses: a 3-period placebo-controlled comparative trial. Aliment Pharmacol Ther 10:749–755, 1996

    Google Scholar 

  5. Grimley, CE, Cotterel J, Mann SG, Stauffer L, Nwokolo CU: Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo. Aliment Pharmacol Ther 11:881–885, 1997

    Google Scholar 

  6. Grimley CE, Constantinides S, Snell CC Mills JG, Nwokolo CU: Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: A comparative study with cimetidine and placebo. Aliment Pharmacol The 11:875–879, 1997

    Google Scholar 

  7. Merki H, Witzel L, Walt RP, Cohnen E, Harre K, Heim J, Mappes A, Rohmel J: Day to day variation of 24 hour intragastric acidity. Gastroenterology 94:887–891, 1988

    Google Scholar 

  8. Dammann HG, Dreyer M, Kangah R, Wolf N: Gastric aspiration technique for pH recording: A critical evaluation of this method. Dig Dis Sci 8(suppl 1):3–9, 1990

    Google Scholar 

  9. Pounder RE, Lanzon-Miller S, Smith JTL, et al: Royal Free Hospital protocol for 24-hour intragastric acidity and plasma gastrin concentration. Dig Dis Sci 8(suppl 1):10–17, 1990

    Google Scholar 

  10. Pounder RE, Prewett EJ: Gastric secretion in health and disease. In The Stomach, Vol 3B. S Gustavsson, D Kumar, DY Graham (eds). London, Churchill Livingston. 1992, pp 53–79

    Google Scholar 

  11. Hunt RH, Cederberg C, Dent J, Halter F, Howden C, Marks I, Rune S, Walt R: Optimizing acid suppression for treatment of acid related diseases. Dig Dis Sci 40:24S–49S, 1995

    Google Scholar 

  12. Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH: Acid suppression in duodenal ulcer: A metanalysis to define optimal dosing with anti-secretory drugs. Gut 28:1120–1127, 1987

    Google Scholar 

  13. Bates S, Sjoden PS, Fellenius J, Nyren O: Blocked and nonblocked acid secretion and reported pain in ulcer, non-ulcer dyspepsia and normal subjects. Gastroenterology 97:376–383, 1989

    Google Scholar 

  14. Mann SG, Murakami A, McCarroll K, Rao AN, Cottrell J, Mehentee J, Morton R: Low-dose famotidine in the prevention of sleep disturbance caused by heartburn after an evening meal. Aliment Pharmacol Ther 9:395–401, 1995

    Google Scholar 

  15. Mann SG, Cottrell J, Murakami A, Stauffer L, Rao AN: Prevention of heartburn relapse by low-dose famotidine: A test meal model for duration of symptom control. Aliment Pharmacol Ther 11:121–127, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamilton, M.I., Sercombe, J. & Pounder, R.E. Decrease of Intragastric Acidity in Healthy Subjects Dosed with Ranitidine 75 mg, Cimetidine 200 mg, or Placebo. Dig Dis Sci 47, 54–57 (2002). https://doi.org/10.1023/A:1013255201858

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013255201858

Navigation